tradingkey.logo

Skye Bioscience Inc <SKYE.OQ> expected to post a loss of 28 cents a share - Earnings Preview

ReutersMar 18, 2025 8:25 PM
  • Skye Bioscience Inc SKYE.OQ SKYE.O is expected to show no change in quarterly revenue when it reports results on March 20 for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Skye Bioscience Inc is for a loss of 28 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Skye Bioscience Inc is $18.00​, above​ its last closing price of $2.53. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.25

-0.25

-0.10

Beat

60.1

Jun. 30 2024

-0.21

-0.19

-0.20

Missed

-2.6

Mar. 31 2024

-0.16

-0.16

-0.18

Missed

-12.5​

Dec. 31 2023

-0.38

-0.38

-0.63

Missed

-65.8

​​

This summary was machine generated March 18 at 20:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI